跳至主要内容
临床试验/CTRI/2021/12/038795
CTRI/2021/12/038795尚未招募3 期

An open-label, Clinical Validation Study to Evaluate the Efficacy and Safety of Unani Pharmacopoeial formulation â?? Qurs-e-Zarishk in SÅ«â??al-Qinya (Anemia)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Hb% <12 gm/dl but > 8 gm/dl
  • 2. Female patients in the age group of 18-65 years
  • 3. With or without following complaints:
  • General weakness
  • Palpitation
  • Breathlessness
  • Restless leg syndrome
  • Thumping or whooshing sound in ear
  • Loss of appetite

排除标准

  • 1. Concomitant medications or history of blood transfusion within prior to 120 days.
  • 2. Known case of any severesystemic diseases such as allergic asthma, chronic kidney diseases, auto-immune disorders(SLE, RA, ulcerative colitis), heart diseases and canceretc.
  • 3. Known cases of any other acute illness.
  • 4. Known case ofhemogolobinopathy or other red celldisordersThalassemias, sickle cell anemia, congenital dyserythropoietic anemia etc.
  • 5. History of hypersensitivity to the investigational drug or herbal drugs.
  • 6. Pregnant and nursing women.

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验